RESEARCH
TRIANGLE PARK, N.C.,/PRNewswire/ -- Marken, the world's
leading Clinical Logistics Organization (CLO), completed and filed
its audited financial results for the fiscal year 2014, which ended
on December 31,
2014. The company outperformed the market and completed its
capital re-structuring program.
Logo
- http://photos.prnewswire.com/prnh/20110930/NY78064LOGO
In
2014, research & development spending in the global
pharmaceutical market returned to modest growth of approximately 4%
after a three year slowdown. Despite a more price-competitive
environment, Marken was able to strengthen its market position and
grow at roughly three times the market rate of growth, delivering
13% year-on-year growth organically, through an expanded portfolio
of services, continued innovation and investment in technology.
The
investments made since 2012, including: new / expanded facilities,
a new network of industry-leading depots, two new IT operating
systems, a new Quality Assurance emphasis and staff, and all new
operating procedures, has allowed Marken to take advantage of
improved market conditions and deliver a return to significant
growth.
A
renewed focus on continuous improvement, known internally as
Marken's Operational Excellence Program was launched in late 2014
based on the application of Lean/Six Sigma techniques. The
Program is now in full implementation and is expected to drive
significant business process improvements while delivering
continued growth and more competitive pricing.
"We are pleased with our 2014 results and the sustained
growth momentum during the early months of 2015, which clearly
indicate the successful operationalization and execution of our
Strategic Plan. This has delivered a turnaround in operating and
financial performance, and impressive year-on-year growth, which is
reflected in very positive trading results for the
year," said Wes
Wheeler, Chief Executive Officer of Marken.
About Marken
Marken
is the leading global clinical supply chain solutions provider
dedicated to the pharmaceutical and life sciences industries,
supporting over 49,000 clinical investigators in more than 150
countries. Marken integrates depot and logistics into solutions
that extend the reach of clinical trials to even the most remote
treatment-naive geographies. Marken is 100% dedicated to the
clinical research industry and a specialist in the transportation
of investigational medical products and medical devices. In
addition to services such as the storage and distribution of
clinical trial materials and drug products to investigators or the
patients directly, Marken maintains a leading position for the
shipment of biological samples and offers additional services such
as shipment lane qualifications as well as GDP, regulatory and
compliance consultancy.
www.marken.com